Cardinal Agrees To Shipping Ban Over Oxycodone Orders

Law360, New York (May 15, 2012, 12:15 PM EDT) -- Cardinal Health Inc. has accepted a two-year ban on shipping prescription drugs from its Florida distribution center to settle allegations that it filled suspicious orders for oxycodone, ending a legal battle with the U.S. Drug Enforcement Administration, the parties said Tuesday.

Cardinal Health agreed to the two-year suspension of the Lakeland, Fla., facility’s DEA registration to ship controlled substances and improve its anti-diversion procedures, which the DEA says were inadequate in light of 2008 settlement it reached with the company over similar allegations.

The Lakeland plant...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.